How has been the historical performance of Samrat Pharma?

Nov 14 2025 11:37 PM IST
share
Share Via
Samrat Pharma's historical performance indicates fluctuating profitability despite growth in net sales and total assets, with net sales rising from INR 137.45 crore in March 2020 to INR 285.86 crore in March 2025, but profit metrics declining significantly in recent years. Operating cash flow turned negative in March 2025, contrasting with previous positive trends.
Answer:
The historical performance of Samrat Pharma shows a fluctuating trend in key financial metrics over the years.

Breakdown:
Samrat Pharma's net sales have seen a gradual increase from INR 137.45 crore in March 2020 to INR 285.86 crore in March 2025, although there was a peak of INR 310.65 crore in March 2023. Total operating income followed a similar pattern, reaching INR 285.86 crore in March 2025. The raw material cost has also risen, from INR 131.80 crore in March 2020 to INR 269.27 crore in March 2025, indicating increased operational costs. Operating profit (PBDIT) experienced significant fluctuations, peaking at INR 24.89 crore in March 2022 before dropping to INR 11.21 crore in March 2025. Profit before tax showed a similar trend, with a high of INR 22.53 crore in March 2023, but falling to INR 9.89 crore in March 2025. Profit after tax also decreased from INR 16.63 crore in March 2023 to INR 7.11 crore in March 2025. The company's total assets increased from INR 58.35 crore in March 2020 to INR 121.49 crore in March 2025, while total liabilities slightly decreased from INR 121.74 crore in March 2024 to INR 121.49 crore in March 2025. Cash flow from operating activities was negative in March 2025 at INR -10 crore, contrasting with positive cash flows in previous years. Overall, while Samrat Pharma has shown growth in sales and assets, profitability has been inconsistent, particularly in the last two years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News